Sitagliptin Phosphate/metformin Hydrochloride Extended Tablet, Film Coated, Extended Release
NDC Package 70293-0003-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Sitagliptin Phosphate/metformin Hydrochloride Extended tablets is a drug for further processing. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by Aiac International Pharma, Llc, this product is identified by NDC 70293-0003.

Identification & Billing

NDC Package Code
70293-0003-2
Package Description
1 BAG in 1 DRUM / 14300 TABLET, FILM COATED, EXTENDED RELEASE in 1 BAG (70293-0003-1)
Product Code
70293-0003
11-Digit Billing Format
70293000302

Clinical Specifications

Proprietary Name
Sitagliptin Phosphate/metformin Hydrochloride Extended
Non-Proprietary Name
Sitagliptin Phosphate/metformin Hydrochloride Extended
Substance Name
Metformin Hydrochloride; Sitagliptin Phosphate
Dosage Form
Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Aiac International Pharma, Llc
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
07-02-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70293-0003-2 identifies a specific commercial package of 1 bag in 1 drum / 14300 tablet, film coated, extended release in 1 bag (70293-0003-1) of Sitagliptin Phosphate/metformin Hydrochloride Extended (UNFINISHED drug), drug for further processing labeled by Aiac International Pharma, Llc. This tablet, film coated, extended release is formulated for use and contains metformin hydrochloride; sitagliptin phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aiac International Pharma, Llc on July 02, 2026. The current certification is valid through December 31, 2027.

How is this Aiac International Pharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70293000302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70293-0003-2
11-Digit CMS (5-4-2)
70293-0003-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.